Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group.
Lancet Neurol 2010. 9(1):77-93.
The MFM is quoted in this article as an assessment tool for patients with Duchenne muscular dystrophy. This artcile had been used as a reference for establishing the guidelines “Diagnosis and management of Duchenne muscular dystrophy” of the “National Guideline Clearinghouse” in the United States
(http://www.ngc.gov/content.aspx?id=15644).

PubMed link

Keywords: Duchenne Muscular Dystrophy, Diagnosis, Management of patients, Recommendation

Articles dans les revues scientifiques

Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients.

D'Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E. Pharmacol Res. 2012. 65(4): 472-9. The main of this monocentric pilot study was to evaluate...

read more